LON:AVCT - Avacta Group Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started GBX 43.40 +0.80 (+1.88 %) (As of 01/22/2019 04:00 PM ET)Previous CloseGBX 42.60Today's RangeGBX 43 - GBX 4652-Week RangeGBX 40 - GBX 98Volume1.09 million shsAverage Volume19,964 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Avacta Group Plc offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom. It operates through two segments, Life Sciences and Animal Health. The company's custom Affimer products are also used in drugs and biomarkers discovery in biotech research and development. In addition, it provides tools and contract services to assist the diagnosis of conditions in animals to enable treatment for veterinarians. The company has a collaboration, licensing, and option agreement with Moderna Therapeutics; research collaboration with OncoSec Medical Incorporated for gene delivery of therapeutic Affimers; and a co-development partnership agreement with Bach Biosciences LLP to develop Affimer drug conjugate therapies. Avacta Group Plc was incorporated in 2003 and is based in Wetherby, the United Kingdom. Receive AVCT News and Ratings via Email Sign-up to receive the latest news and ratings for AVCT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolLON:AVCT Previous Symbol CUSIPN/A Webwww.avacta.comkey-information Phone+44-1904-217070Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees114 Outstanding SharesN/AMarket CapN/A OptionableNot Optionable Avacta Group (LON:AVCT) Frequently Asked Questions What is Avacta Group's stock symbol? Avacta Group trades on the London Stock Exchange (LON) under the ticker symbol "AVCT." What price target have analysts set for AVCT? 0 brokers have issued 1 year target prices for Avacta Group's stock. Their predictions range from GBX 200 to GBX 200. On average, they expect Avacta Group's stock price to reach GBX 200 in the next twelve months. This suggests a possible upside of 360.8% from the stock's current price. View Analyst Price Targets for Avacta Group. Has Avacta Group been receiving favorable news coverage? Media stories about AVCT stock have trended very positive this week, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Avacta Group earned a media sentiment score of 3.2 on InfoTrie's scale. They also assigned news stories about the biotechnology company a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future. Who are some of Avacta Group's key competitors? Some companies that are related to Avacta Group include Activecare (ACAR), Advanced Oncotherapy (AVO), Airware Labs (AIRW), Anteo Diagnostics (ADO), Aurora Spine (ASG), Azure Healthcare (AZV), Cannabix Technologies (BLOZF), Cochlear (COH), ConvaTec Group (CTEC), Creo Medical Group (CREO), Draegerwerk AG & Co KGaA (DRW3), Electromed (ELMD), Ellex Medical Lasers (ELXMF), EMvision Medical Devices (EMV) and Fisher & Paykel Healthcare (FPH). Who are Avacta Group's key executives? Avacta Group's management team includes the folowing people: Prof. Alastair Smith, CEO & Exec. DirectorMr. Tony Gardiner, CFO, Company Sec. & Exec. Director (Age 47)Dr. Michael Albin, AdviserDr. Matt Johnson, Chief Technology OfficerDr. Amrik Basran Ph.D., Chief Scientific Officer How do I buy shares of Avacta Group? Shares of AVCT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Avacta Group's stock price today? One share of AVCT stock can currently be purchased for approximately GBX 43.40. What is Avacta Group's official website? The official website for Avacta Group is https://www.avacta.com/key-information. How can I contact Avacta Group? Avacta Group's mailing address is Unit 20, Ash Way, WETHERBY, LS23 7FA, United Kingdom. The biotechnology company can be reached via phone at +44-1904-217070. MarketBeat Community Rating for Avacta Group (LON AVCT)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 189 (Vote Outperform)Underperform Votes: 168 (Vote Underperform)Total Votes: 357MarketBeat's community ratings are surveys of what our community members think about Avacta Group and other stocks. Vote "Outperform" if you believe AVCT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVCT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/22/2019 by MarketBeat.com StaffFeatured Article: What is a stock split?